PO
Predictive Oncology Inc.
SEC filingOther · Pittsburgh, PA
Amount raised$50.8Msold at filing
Total offering$50.8M
Investors in the raise29count reported to the SEC
FiledOct 22, 2025first sale Oct 7, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Matthew S. HawrylukDirector
Chuck S. NuzumDirector
Josh S. BlacherExecutive Officer
Shawn S. MatthewsDirector
Veena F. RaoDirector
Gregory S. St. Clair, Sr.Director
Raymond F. VennareExecutive Officer, Director
Thomas L. McLaughlinExecutive Officer
Dan S. HadleyDirector
Executive officers, directors and promoters as listed on the Form D.